Essais CLiniques Accessibles Interconnectés pour la Recherche ouverts à l'Ecosystème
0.1.1 - ci-build
Essais CLiniques Accessibles Interconnectés pour la Recherche ouverts à l'Ecosystème
0.1.1 - ci-build
Publication Build: This will be filled in by the publication tooling
| Draft as of 2023-10-09 |
{
"resourceType" : "ConceptMap",
"id" : "eclaire-study-phase-concept-map",
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Mapping from <a href=\"ValueSet-eclaire-study-phase-source-vs.html\">Value Set de la phase de l'essai tel que définie dans la base ECLAIRE</a> to <a href=\"ValueSet-eclaire-study-phase-vs.html\">Value Set type de phase de l'essai clinique</a></p><p>DRAFT (not intended for production usage). Published on 2023-10-09 08:51:32+0000 by ANS (ANS: <a href=\"https://esante.gouv.fr\">https://esante.gouv.fr</a>). </p><div><p>Correspondance entre la phase définie dans la base Eclaire et le ValueSet https://interop.esante.gouv.fr/ig/fhir/eclaire/ValueSet-eclaire-study-phase-vs</p>\n</div><br/><p><b>Group 1</b>Mapping from <a href=\"CodeSystem-eclaire-study-phase-source-code-system.html\">Définition des phase de l'essai utilisés dans la base de données ECLAIRE</a> to <a href=\"http://terminology.hl7.org/5.3.0/CodeSystem-research-study-phase.html\">ResearchStudyPhase</a></p><table class=\"grid\"><tr><td><b>Source Code</b></td><td><b>Relationship</b></td><td><b>Target Code</b></td></tr><tr><td>jarde-early (Jardé phase précoce)</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#equivalent\" title=\"equivalent\">is equivalent to</a></td><td>phase-1</td></tr><tr><td>jarde-early (Jardé phase précoce)</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#equivalent\" title=\"equivalent\">is equivalent to</a></td><td>phase-1-phase-2 (Phase 1/Phase 2)</td></tr><tr><td>phase-I-first-admin (Human Pharmacology (Phase I) - First administration to humans)</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#wider\" title=\"wider\">maps to wider concept</a></td><td>phase-1</td></tr><tr><td>phase-I-bioequivalence (Human Pharmacology (Phase I) - Bioequivalence Study)</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#wider\" title=\"wider\">maps to wider concept</a></td><td>phase-1</td></tr><tr><td>phase-I-other (Human Pharmacology (Phase I) - Other)</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#wider\" title=\"wider\">maps to wider concept</a></td><td>phase-1</td></tr><tr><td>phase-I-II-first-admin (Phase I and Phase II (Integrated) - First administration to humans)</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#wider\" title=\"wider\">maps to wider concept</a></td><td>phase-1-phase-2 (Phase 1/Phase 2)</td></tr><tr><td>phase-I-II-first-bioequivalence (Phase I and Phase II (Integrated) - Bioequivalence Study)</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#wider\" title=\"wider\">maps to wider concept</a></td><td>phase-1-phase-2 (Phase 1/Phase 2)</td></tr><tr><td>phase-I-II-other (Phase I and Phase II (Integrated) - Other)</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#wider\" title=\"wider\">maps to wider concept</a></td><td>phase-1-phase-2 (Phase 1/Phase 2)</td></tr><tr><td>phase-II (Therapeutic exploratory (Phase II))</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#equivalent\" title=\"equivalent\">is equivalent to</a></td><td>phase-2</td></tr><tr><td>phase-II-III (Phase II and Phase III (Integrated))</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#equivalent\" title=\"equivalent\">is equivalent to</a></td><td>phase-2-phase-3 (Phase 2/Phase 3)</td></tr><tr><td>phase-III (Therapeutic confirmatory (Phase III))</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#equivalent\" title=\"equivalent\">is equivalent to</a></td><td>phase-3</td></tr></table><hr/><p><b>Group 2</b>Mapping from <a href=\"CodeSystem-eclaire-study-phase-source-code-system.html\">Définition des phase de l'essai utilisés dans la base de données ECLAIRE</a> to <a href=\"CodeSystem-eclaire-study-phase-code-system.html\">Définition des type de phase de l'essai cliniques incluant https://hl7.org/fhir/R4/valueset-research-study-phase.html</a></p><table class=\"grid\"><tr><td><b>Source Code</b></td><td><b>Relationship</b></td><td><b>Target Code</b></td></tr><tr><td>phase-III-IV (Phase III and phase IV (Integrated))</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#equivalent\" title=\"equivalent\">is equivalent to</a></td><td>phase-3-phase-4 (Phase 3 and phase 4)</td></tr></table></div>"
},
"url" : "https://interop.esante.gouv.fr/ig/fhir/eclaire/ConceptMap/eclaire-study-phase-concept-map",
"version" : "0.1.1",
"name" : "FHIR_Eclaire_phase_concept_map",
"title" : "FHIR/Eclaire ResearchStudy phase Use Mapping",
"status" : "draft",
"experimental" : true,
"date" : "2023-10-09T08:51:32+00:00",
"publisher" : "ANS",
"contact" : [
{
"name" : "ANS",
"telecom" : [
{
"system" : "url",
"value" : "https://esante.gouv.fr"
}
]
}
],
"description" : "Correspondance entre la phase définie dans la base Eclaire et le ValueSet https://interop.esante.gouv.fr/ig/fhir/eclaire/ValueSet-eclaire-study-phase-vs",
"sourceUri" : "eclaire-study-phase-source-vs",
"targetUri" : "eclaire-study-phase-vs",
"group" : [
{
"source" : "eclaire-study-phase-source-code-system",
"target" : "http://terminology.hl7.org/CodeSystem/research-study-phase",
"element" : [
{
"code" : "jarde-early",
"target" : [
{
"code" : "phase-1",
"equivalence" : "equivalent"
}
]
},
{
"code" : "jarde-early",
"target" : [
{
"code" : "phase-1-phase-2",
"equivalence" : "equivalent"
}
]
},
{
"code" : "phase-I-first-admin",
"target" : [
{
"code" : "phase-1",
"equivalence" : "wider"
}
]
},
{
"code" : "phase-I-bioequivalence",
"target" : [
{
"code" : "phase-1",
"equivalence" : "wider"
}
]
},
{
"code" : "phase-I-other",
"target" : [
{
"code" : "phase-1",
"equivalence" : "wider"
}
]
},
{
"code" : "phase-I-II-first-admin",
"target" : [
{
"code" : "phase-1-phase-2",
"equivalence" : "wider"
}
]
},
{
"code" : "phase-I-II-first-bioequivalence",
"target" : [
{
"code" : "phase-1-phase-2",
"equivalence" : "wider"
}
]
},
{
"code" : "phase-I-II-other",
"target" : [
{
"code" : "phase-1-phase-2",
"equivalence" : "wider"
}
]
},
{
"code" : "phase-II",
"target" : [
{
"code" : "phase-2",
"equivalence" : "equivalent"
}
]
},
{
"code" : "phase-II-III",
"target" : [
{
"code" : "phase-2-phase-3",
"equivalence" : "equivalent"
}
]
},
{
"code" : "phase-III",
"target" : [
{
"code" : "phase-3",
"equivalence" : "equivalent"
}
]
}
]
},
{
"source" : "eclaire-study-phase-source-code-system",
"target" : "eclaire-study-phase-code-system",
"element" : [
{
"code" : "phase-III-IV",
"target" : [
{
"code" : "phase-3-phase-4",
"equivalence" : "equivalent"
}
]
}
]
}
]
}
IG © 2020+ ANS. Package ans.fhir.fr.eclaire#0.1.1 based on FHIR 4.0.1. Generated 2023-10-09
Links: Table of Contents |
QA Report
| New Issue